EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The association between BMI and BRAFV600E mutation may differ by primary tumor size

Hyunju Park iD, Jung Heo, Hyun Jin Ryu, Min-Ji Kim, Young Lyun Oh, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon Chung iD

European Thyroid Journal · 2024

DOI: 10.1530/etj-23-0255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Thyroid Journal, 2024. Verfasst von Hyunju Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Body Mass Index, Mutation, Thyroid Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Previous reports suggest that a high body mass index (BMI) increases the risk of thyroid carcinoma. However, it remains unclear whether a high BMI is associated with the risk of the BRAFV600E mutation. We aimed to assess whether a high BMI is associated with an increased risk of the BRAFV600E mutation. Design and Methods We screened 6558 PTC patients who had undergone BRAFV600E mutation testing between January 2009 and December 2017. After exclusion, 6438 PTC patients were enrolled. We used logistic regression, and restricted cubic spline plots of the adjusted odds ratios (ORs) were illustrated to model the relationship between BMI and the BRAFV600E mutation.

Results

Of the 6438 patients, 5102 (79.2%) had the BRAFV600E mutation, and 4954 (76.9%) were female. The median BMI was 23.8 (21.6–26.2) kg/m 2 . The primary tumor size was ≤1 cm in 4226 patients (65.6%) and >1 cm in 2212 patients (34.4%). The BRAFV600E mutation was significantly associated with high BMI only in patients with a primary tumor size >1 cm (OR: 1.034; 95% CI: 1.003–1.065; P = 0.029), whereas no clear association was found in patients with a primary tumor size ≤1 cm (OR: 1.007; 95% CI: 0.984–1.030; P = 0.570). Gender was not a significant factor in either group.

Conclusions

Our study found that a higher BMI was positively associated with the BRAFV600E mutation in patients with a primary tumor size >1 cm. These results suggest that the association between BMI and the BRAFV600E mutation status differs depending on primary tumor size. Significance Statement Obesity has been suggested as a potential risk factor for thyroid carcinoma. The aim of this study was to assess the association between BMI and the BRAFV600E mutation. In this study, the BRAFV600E mutation was significantly associated with a high BMI only in a primary tumor size >1 cm (OR: 1.034; P = 0.029). No clear association was found in patients with a primary tumor size ≤1 cm (OR: 1.007; P = 0.570). The association between BMI and the BRAFV600E mutation status differs depending on the primary tumor size.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafBody Mass IndexMutationThyroid NeoplasmsHumansFemaleMaleMiddle AgedAdultTumor BurdenThyroid Cancer, PapillaryAgedRisk FactorsObesity

Stichwörter der Autor:innen

BRAFV600E mutationbody mass indexpapillary thyroid carcinomaprimary tumor size

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang-si, Gyeonggi-do, Korea.
  • Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Statistics and Data Center, Samsung Medical Center, Research Institute for Future Medicine.
  • Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ORCID-Profile: Hyunju Park, Jae Hoon Chung

Zitieren

APA

Park, H., Heo, J., Ryu, H. J., Kim, M. J., Oh, Y. L., Kim, T. H., Kim, S. W., & Chung, J. H. (2024). The association between BMI and BRAFV600E mutation may differ by primary tumor size. European Thyroid Journal. https://doi.org/10.1530/etj-23-0255

Vancouver

Park H, Heo J, Ryu HJ, Kim MJ, Oh YL, Kim TH, et al. The association between BMI and BRAFV600E mutation may differ by primary tumor size. European Thyroid Journal. 2024. doi:10.1530/etj-23-0255

BibTeX
@article{Park2024,
  author = {Park, Hyunju and Heo, Jung and Ryu, Hyun Jin and Kim, Min-Ji and Oh, Young Lyun and Kim, Tae Hyuk and Kim, Sun Wook and Chung, Jae Hoon},
  title = {The association between BMI and BRAFV600E mutation may differ by primary tumor size},
  journal = {European Thyroid Journal},
  year = {2024},
  doi = {10.1530/etj-23-0255}
}
Kostenlos starten →